{
    "clinical_study": {
        "@rank": "53592", 
        "arm_group": [
            {
                "arm_group_label": "Insulin degludec/insulin aspart", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Insulin detemir", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is conducted in Asia, Europe and North and South America. The aim of the trial is\n      to investigate the efficacy and safety of insulin degludec/insulin aspart once daily plus\n      insulin aspart for the remaining meals in children and adolescents with type 1 diabetes\n      mellitus."
        }, 
        "brief_title": "A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetes Mellitus, Type 1"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent obtained before any trial related activities. Trial related\n             activities are any procedures that are carried out as part of the trial, including\n             activities to determine suitability for the trial\n\n          -  Subjects diagnosed with type 1 diabetes mellitus\n\n          -  HbA1c below or equal to 11.0%\n\n        Exclusion Criteria:\n\n          -  Known hypoglycaemic unawareness or recurrent severe hypoglycaemic events as judged by\n             the investigator\n\n          -  More than 1 episode of diabetic ketoacidosis requiring hospitalisation within the\n             last 3 months prior to Visit 1 (Screening)\n\n          -  Any chronic disorder or significant concomitant disease, which in the investigator's\n             opinion might jeopardise the subject's safety or compliance with the protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "346", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835431", 
            "org_study_id": "NN5401-3816", 
            "secondary_id": [
                "2012-003566-41", 
                "U1111-1133-0958", 
                "PIP no. be confirmed"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Insulin degludec/insulin aspart", 
                "description": "Administered subcutaneously (s.c., under the skin) once daily with a main meal. Dose individually adjusted.", 
                "intervention_name": "insulin degludec/insulin aspart", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Insulin degludec/insulin aspart", 
                "description": "Administered s.c. with the remaining meals. Dose individually adjusted.", 
                "intervention_name": "insulin aspart", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Insulin detemir", 
                "description": "Administered s.c. once or twice daily. Dose individually adjusted. Subjects will continue with their pre-trial dosing scheme (once (OD) or twice daily (BID)) and will be allowed to switch from OD to BID dosing.", 
                "intervention_name": "insulin detemir", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Insulin detemir", 
                "description": "Administered s.c. at meal-times. Dose individually adjusted.", 
                "intervention_name": "insulin aspart", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Insulin aspart", 
                "Insulin", 
                "Insulin, Long-Acting"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 26, 2014", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85053"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85724"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95816"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80045"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32207-8426"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maitland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32751"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32901"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tallahassee", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32308"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30318"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Idaho Falls", 
                        "country": "United States", 
                        "state": "Idaho", 
                        "zip": "83404-7542"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62703"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iowa City", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52242"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40503"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21229"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01655"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64111"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14222"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "74135"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75231"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "Sao Paulo", 
                        "zip": "01244-030"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "HIT 2M4"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zagreb", 
                        "country": "Croatia", 
                        "zip": "10 000"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olomouc", 
                        "country": "Czech Republic", 
                        "zip": "77520"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangalore", 
                        "country": "India", 
                        "zip": "560034"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zerifin", 
                        "country": "Israel", 
                        "zip": "70300"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skopje", 
                        "country": "Macedonia, The Former Yugoslav Republic of", 
                        "zip": "1000"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warszawa", 
                        "country": "Poland", 
                        "zip": "04-730"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint-Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "193144"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia", 
                        "zip": "11070"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ljubljana", 
                        "country": "Slovenia", 
                        "zip": "1525"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johannesburg", 
                        "country": "South Africa", 
                        "state": "Gauteng", 
                        "zip": "2193"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Belgium", 
                "Brazil", 
                "Canada", 
                "Croatia", 
                "Czech Republic", 
                "India", 
                "Israel", 
                "Macedonia, The Former Yugoslav Republic of", 
                "Poland", 
                "Russian Federation", 
                "Serbia", 
                "Slovenia", 
                "South Africa", 
                "Spain"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus", 
        "overall_contact": {
            "email": "clinicaltrials@novonordisk.com", 
            "last_name": "Novo Nordisk"
        }, 
        "overall_official": {
            "affiliation": "Novo Nordisk A/S", 
            "last_name": "Global Clinical Registry (GCR, 1452)", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Brazil: Ministry of Health", 
                "Canada: Health Canada", 
                "Czech Republic: State Institute for Drug Control", 
                "Croatia: Ministry of Health and Social Care", 
                "India: Drugs Controller General of India", 
                "Israel: Ministry of Health", 
                "Macedonia, The Former Yugoslav Republic of: Ministry of Health", 
                "Poland: Ministry of Health", 
                "Russia: Ministry of Health of the Russian Federation", 
                "Serbia: Agency for Drugs and Medicinal Devices", 
                "Slovenia: Agency for Medicinal Products - Ministry of Health", 
                "South Africa: Medicines Control Council", 
                "Spain: Ministry of Health", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in HbA1c (glycosylated haemoglobin) (%)", 
            "safety_issue": "No", 
            "time_frame": "Week 0, week 16"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835431"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in fasting plasma glucose", 
                "safety_issue": "No", 
                "time_frame": "Week 0, week 16"
            }, 
            {
                "measure": "Incidence of treatment emergent adverse events (TEAEs)", 
                "safety_issue": "No", 
                "time_frame": "After 16 weeks of treatment"
            }, 
            {
                "measure": "Number of treatment emergent confirmed hypoglycaemic episodes (plasma glucose (PG) below 3.1 mmol/L (56 mg/dL) or severe hypoglycaemia)", 
                "safety_issue": "No", 
                "time_frame": "After 16 weeks of treatment"
            }, 
            {
                "measure": "Number of treatment emergent nocturnal confirmed hypoglycaemic episodes", 
                "safety_issue": "No", 
                "time_frame": "After 16 weeks of treatment"
            }, 
            {
                "measure": "Number of hyperglycaemic episodes (PG above 14.0 mmol/L (250 mg/dL) where subject looks/feels ill", 
                "safety_issue": "No", 
                "time_frame": "After 16 weeks of treatment"
            }, 
            {
                "measure": "Number of hyperglycaemic episodes (PG above 14.0 mmol/L (250 mg/dL) where subject looks/feels ill with ketosis (blood ketones above 1.5 mmol/L)", 
                "safety_issue": "No", 
                "time_frame": "After 16 weeks of treatment"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}